Lung Cancer
📧 Sign up to get email alerts when something new happens for Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 [Phase 1, Phase 2]
Phase 1/2 trial update for IMM2902 in patients with HER2-expressing advanced solid tumors including advanced solid tumors, advanced lung can…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Educating QUitline Callers About Lung Cancer Screening [Phase 3]
A Phase 3 clinical trial updating QUITLINE callers about lung cancer screening has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules [Phase 2]
Phase 2 trial update for OTL38 injection used for intraoperative imaging of folate receptor-positive lung nodules; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC) [Phase 2]
Phase 2 clinical trial update investigating chemo-immunotherapy induction followed by hypo-radiotherapy in locally advanced non-small cell l…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting [Phase 3]
Phase 3 trial update for ELUCIDATE investigating folate receptor targeting to enable lung cancer identification; study completed with result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer [Phase 2]
Phase 2 trial evaluating intravenous GC4419 for reducing incidence and severity of esophagitis in lung cancer patients undergoing chemoradio…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
A clinical trial update on collecting and studying tissue samples from patients with HIV-associated malignancies; the study is terminated wi…
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer [NA]
Clinical trial update on CBT-I for chronic insomnia in lung cancer patients, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Nitrous Oxide for Identifying the Intersegmental Plane in Segmentectomy: A Randomized Controlled Trial [NA]
A completed randomized controlled trial evaluating nitrous oxide to identify the intersegmental plane during segmentectomy for pulmonary nod…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Bronchoscopic Laser Ablation of Peripheral Lung Tumors [NA]
Clinical trial on bronchoscopic laser ablation for peripheral lung tumors was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer. [Phase 3]
Phase 3 trial evaluating TQB2450 with chemotherapy followed by anlotinib for first-line treatment of advanced squamous non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: A Prevention Trial of Canakinumab in Subjects at High Risk for Lung Cancer [Phase 3]
A Phase 3 prevention trial of canakinumab in high-risk individuals for lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating nivolumab, cabozantinib S-malate, and ipilimumab in recurrent stage IV non-small cell lung cancer has completed wit…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY] [Phase 4]
A Phase 4 clinical trial evaluating blood tumor mutational burden (TMB) as a biomarker for the efficacy of atezolizumab in malignant lung ne…
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Lazertinib 160mg in EGFR T790M NSCLC [Phase 2]
Phase 2 clinical trial update for lazertinib 160mg in EGFR T790M non-small cell lung cancer (Stage IV).
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) [Phase 1, Phase 2]
Open-label, dose-escalation study of pemigatinib in advanced malignancies (FIGHT-101) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant afatinib for potentially resectable stage III EGFR mutation-positive lung adenocarcinoma has c…
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update evaluating carboplatin and paclitaxel with or without ISIS 3521 in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Nutrition and Pharmacological Algorithm for Oncology Patients Study [Phase 4]
Phase 4 trial update for a nutrition and pharmacological algorithm in oncology patients; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Clinical Description of a Bronchoscopic Approach to Ablate Lung Nodules Using the Emprint™ Ablation Catheter
Clinical trial update describing a bronchoscopic ablation approach to lung nodules using the Emprint ablation catheter; completed with resul…
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer [Phase 2]
Phase 2 trial of REGN2810 (cemiplimab) in combination with ipilimumab for advanced non-small cell lung carcinoma has been terminated with po…
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: Electrocautery Ablation for the Prevention of Lung Cancer [Phase 2, Phase 3]
Phase 2/3 trial of electrocautery ablation to prevent lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A clinical trial update for T3011 administered intravenously in patients with advanced solid tumors, including various cancer types, spannin…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update for AP-L1898 capsule in patients with lung cancer is provided, with the status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: Brigatinib Before Brain Irradiation Trial (B3i Trial) [Phase 2]
Phase 2 trial update for brigatinib before brain irradiation in patients with brain metastases and lung cancer has been terminated; results …